Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.19.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity

The activity for the Company’s 2009 Stock Option Plan, 2014 Plan and 2015 Inducement Plan, or 2015 Plan, for the three months ended March 31, 2019, is summarized as follows:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic

Value ($000)

 

Outstanding — January 1, 2019

 

 

4,052,913

 

 

$

4.37

 

 

 

7.23

 

 

$

 

Granted

 

 

1,270,500

 

 

$

1.26

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Forfeited/Cancelled

 

 

(12,915

)

 

$

9.35

 

 

 

 

 

 

 

 

 

Outstanding — March 31, 2019

 

 

5,310,498

 

 

$

3.62

 

 

 

7.69

 

 

$

333

 

Exercisable — March 31, 2019

 

 

2,621,464

 

 

$

5.43

 

 

 

6.29

 

 

$

13

 

Vested or expected to vest — March 31, 2019

 

 

5,310,498

 

 

$

3.62

 

 

 

7.69

 

 

$

333

 

Schedule of Restricted Stock Units ("RSU") Activity

Restricted stock unit ("RSU") activity under the 2014 Plan for the three months ended March 31, 2019, is summarized as follows:

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

Per Share

 

Non-vested at December 31, 2018

 

 

111,891

 

 

$

2.06

 

Granted

 

 

901,000

 

 

$

1.38

 

Vested

 

 

(22,590

)

 

$

2.30

 

Forfeited/Cancelled

 

 

 

 

$

 

Non-vested at March 31, 2019

 

 

990,301

 

 

$

1.43

 

Stock-Based Compensation Expense Related to Stock Options

Stock-based compensation expense related to stock options is included in the following line items in the accompanying statements of operations (in thousands):

 

 

Three Months Ended March 31,

 

 

 

 

2019

 

 

2018

 

 

Research and development

 

$

158

 

 

$

108

 

 

Selling, general and administrative

 

 

334

 

 

 

317

 

 

Total

 

$

492

 

 

$

425